Fate Therapeutics Inc Asset Resilience Ratio

Latest as of September 2025: 50.86%

Fate Therapeutics Inc asset resilience ratio. Fate Therapeutics Inc (FATE) has an Asset Resilience Ratio of 50.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Fate Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$174.80 Million

Cash + Short-term Investments

Total Assets

$343.67 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Fate Therapeutics Inc (2013–2024)

Asset resilience ratio of Fate Therapeutics Inc from 2013 to 2024. This chart shows how Fate Therapeutics Inc's Asset Resilience Ratio has changed over time. Read FATE total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Fate Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Fate Therapeutics Inc's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$174.80 Million	50.86%
Total Liquid Assets	$174.80 Million	50.86%

Asset Resilience Insights

Very High Liquidity: Fate Therapeutics Inc maintains exceptional liquid asset reserves at 50.86% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Fate Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Fate Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Immunovant Inc NASDAQ:IMVT	Biotechnology	98.50%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%

Fate Therapeutics Inc Asset Resilience Ratio by Year (2013–2024)

Fate Therapeutics Inc asset resilience ratio by year from 2013 to 2024. The table below shows the annual Asset Resilience Ratio data for Fate Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	55.14%	$243.01 Million	$440.69 Million	+1.15pp
2023-12-31	53.99%	$273.31 Million	$506.22 Million	+0.86pp
2022-12-31	53.13%	$374.89 Million	$705.56 Million	+0.79pp
2021-12-31	52.34%	$482.33 Million	$921.46 Million	+1.65pp
2020-12-31	50.70%	$315.57 Million	$622.46 Million	+10.46pp
2019-12-31	40.23%	$121.61 Million	$302.27 Million	+35.31pp
2018-12-31	4.93%	$10.49 Million	$213.03 Million	-6.47pp
2017-12-31	11.39%	$12.00 Million	$105.29 Million	+7.71pp
2016-12-31	3.69%	$3.50 Million	$95.05 Million	--
2015-12-31	0.00%	$0.00	$67.96 Million	--
2014-12-31	0.00%	$0.00	$51.20 Million	--
2013-12-31	0.00%	$0.00	$55.58 Million	--

pp = percentage points

About Fate Therapeutics Inc

NASDAQ:FATE USA Biotechnology

Market Cap

$211.67 Million

Market Cap Rank

#17902 Global

#4218 in USA

Share Price

$1.84

Change (1 day)

-0.81%

52-Week Range

$0.96 - $3.11

All Time High

$117.40